Literature DB >> 12010948

To whom do the research findings apply?

Curt D Furberg1.   

Abstract

Mesh：

Year:  2002        PMID： 12010948      PMCID： PMC1767149          DOI： 10.1136/heart.87.6.570

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  13 in total

1.  The challenge of minority recruitment in clinical trials for AIDS.

Authors:  W el-Sadr; L Capps
Journal:  JAMA       Date:  1992-02-19       Impact factor: 56.272

2.  The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.

Authors:  G H Guyatt; J L Keller; R Jaeschke; D Rosenbloom; J D Adachi; M T Newhouse
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391

Review 3.  Incommunicable knowledge? Interpreting and applying the results of clinical trials and meta-analyses.

Authors:  G D Smith; M Egger
Journal:  J Clin Epidemiol       Date:  1998-04       Impact factor: 6.437

4.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

Authors:  L F Hutchins; J M Unger; J J Crowley; C A Coltman; K S Albain
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

Review 5.  Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Authors:  C D Furberg; B M Psaty; M Pahor; M H Alderman
Journal:  Ann Intern Med       Date:  2001-12-18       Impact factor: 25.391

6.  Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

Authors:  S J Robins; D Collins; J T Wittes; V Papademetriou; P C Deedwania; E J Schaefer; J R McNamara; M L Kashyap; J M Hershman; L F Wexler; H B Rubins
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

7.  What fraction of hospital ulcer patients is eligible for prospective drug trials?

Authors:  I Kääriäinen; P Sipponen; M Siurala
Journal:  Scand J Gastroenterol Suppl       Date:  1991

8.  Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Comparability of entry characteristics and survival in randomized patients and nonrandomized patients meeting randomization criteria.

Authors: 
Journal:  J Am Coll Cardiol       Date:  1984-01       Impact factor: 24.094

9.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

10.  Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Authors: 
Journal:  N Engl J Med       Date:  1980-10-30       Impact factor: 91.245
View more
  3 in total

1.  Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment.

Authors:  Cristiana Vitale; Giuseppe Rosano; Massimo Fini
Journal:  Wien Klin Wochenschr       Date:  2016-09-21       Impact factor: 1.704

2.  The winged chariot and the iron cages.

Authors:  Norman P S Campbell
Journal:  Ulster Med J       Date:  2006-09

3.  The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review.

Authors:  Bhanu Prasad Venkatesulu; Viveksandeep Thoguluva Chandrasekar; Prashanth Giridhar; Pragathee V; Harsh K Patel; Jacob Manteuffel
Journal:  J Med Virol       Date:  2020-08-02       Impact factor: 20.693
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.